AMB ExpressMicrobiologyPeer-reviewed journal article
An efficient gene targeting system using Δku80 and functional analysis of Cyp51A in Trichophyton rubrum.
Abstract
Trichophyton rubrum is one of the most frequently isolated fungi in patients with dermatophytosis. Despite its clinical significance, the molecular mechanisms of drug resistance and pathogenicity of T. rubrum remain to be elucidated because of the lack of genetic tools, such as efficient gene targeting systems. In this study, we generated a T. rubrum strain that lacks the nonhomologous end-joining-related gene ku80 ({Delta}ku80) and then developed a highly efficient genetic recombination system with gene targeting efficiency that was 46 times higher than that using the wild-type strain. Cyp51A and Cyp51B are 14--lanosterol demethylase isozymes in T. rubrum that promote ergosterol biosynthesis and are the targets of azole antifungal drugs. The expression of cyp51A mRNA was induced by the addition of the azole antifungal drug efinaconazole, whereas no such induction was detected for cyp51B, suggesting that Cyp51A functions as an azole-responsive Cyp51 isozyme. To explore the contribution of Cyp51A to susceptibility to azole drugs, the neomycin phosphotransferase (nptII) gene cassette was inserted into the cyp51A 3'-UTR region of {Delta}ku80 to destabilize the mRNA of cyp51A. In this mutant, although the expression level of cyp51A mRNA was comparable to that of the parent strain, the induction of cyp51A mRNA expression by efinaconazole was diminished. The minimum inhibitory concentration for several azole drugs of this strain was reduced, suggesting that dermatophyte Cyp51A contributes to the tolerance for azole drugs. These findings suggest that an efficient gene targeting system using {Delta}ku80 in T. rubrum is applicable for analyzing genes encoding drug targets. Key PointsO_LIA novel gene targeting system using {Delta}ku80 strain was established in T. rubrum C_LIO_LICyp51A in T. rubrum responds to the azole antifungal drug efinaconazole C_LIO_LICyp51A contributes to azole drug tolerance in T. rubrum C_LI
- organism: fungi (other)
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 7
- FWCI
- 0.78
- Field percentile
- top 36%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synergistic effects of Cyp51 isozyme-specific azole antifungal agents on fungi with multiple cyp51 isozyme genes
Masaki Ishii, Kazuki Ishikawa, … Shinya Ohata·Antimicrobial Agents and ChemotherapyPeer-reviewed·Sep 26, 2025
- Identification of novel mutations contributing to azole tolerance of Aspergillus fumigatus through in vitro exposure to tebuconazole
T. Toyotome, K. Onishi, … H. Takahashi·bioRxiv·Jul 20, 2020
- Loss of a conserved C-terminal region of the Aspergillus fumigatus AtrR transcriptional regulator leads to a gene-specific defect in target gene expression
Shivani Ror, Mark A. Stamnes, Scott Moye-Rowley·bioRxiv·May 22, 2024
- Complex and critical roles for the AtrR transcription factor in control of cyp51A expression in Aspergillus fumigatus
S. Paul, P. E. Verweij, … W. S. Moye-Rowley·bioRxiv·Jan 28, 2022
- Cas9/CRISPR genome editing to demonstrate the contribution of Cyp51A Gly138Ser to azole resistance in Aspergillus fumigatus
T. Umeyama, Y. Hayashi, … Y. Miyazaki·bioRxiv·May 1, 2018
- Dissecting allele-specific fungicide resistance mechanisms by heterologous expression of the demethylase inhibitor target gene Cyp51 in a phytopathogen model
Katherine G. Zulak, Steven Chang, … Francisco J. López-Ruiz·bioRxiv·Oct 16, 2025